Tożsamość

Naltrexone EP Impurity E

CAS 767615-69-0 · C24H29NO4

01Tożsamość

Lazychem IDLC-23071
CAS RN767615-69-0
PubChem CID124635549
Molecular formulaC24H29NO4
Molecular weight395.5 g/mol
IUPAC name3-(Cyclopropylmethoxy)-17-(cyclopropylmethyl)-4,5α-epoxy-14-hydroxymorphinan-6-one
InChIKeyCWBIRQZMHBILAR-QLBRKBSLSA-N

02Struktura i stereochemia

2D structurePubChem CID 124635549
Two-dimensional chemical structure of Naltrexone EP Impurity E, CAS 767615-69-0
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 7 rings, includes aromatic atoms, includes aliphatic carbon, has 4 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres4
Ring count7
Secondary amines0
Tertiary amines1
SMILESC1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)OCC7CC7)O5)O
InChINie podano

03Stereochemistry

The published structure contains 4 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres4Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 16Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status w Indiach

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nazwy i powiązania

API i lek macierzysty

Naltrexone

Zanieczyszczenia i związki pokrewne

Nazwy i powiązania

  • Morphinan-6-one, 3-(cyclopropylmethoxy)-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5a)
  • (5a)-3-(Cyclopropylmethoxy)-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxymorphinan-6-one
  • 3-Cyclopropylmethylnaltrexone
  • 3-O-Cyclopropylmethylnaltrexone
  • Naltrexone EP Impurity E
  • 767615-69-0
  • 3-O-Cyclopropylmethylnaltrexone (1mg/ml in Acetonitrile)
  • (5alpha)-3-(Cyclopropylmethoxy)-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-morphinan-6-one
  • Naltrexone impurity E
  • ZKP48WH232
  • IN167083
  • (5?)-3-(Cyclopropylmethoxy)-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxymorphinan-6-one

Zanieczyszczenia i związki pokrewne

06Źródła